SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Canʼt Get No Satisfaction? Will Pay for Performance Help?
6 references·5 citing·42 second hop
Canʼt Get No Satisfaction? Will Pay for Performance Help? (2010)Canʼt Get No Satisfaction? Will Pay for P…Uncertainty and the Evaluation of Public Investment Decisions (2013)Uncertainty and the Evaluatio…Expected value of information and decision making in HTA (2006)Expected value of information…Valuation and management of money-back guarantee options (2002)Valuation and management of m…Demonstrations and money-back guarantees: market mechanisms to reduce uncertainty (2001)Demonstrations and money-back…Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. (1993)Guidelines for the adoption o…Economic Efficiency and the Distribution of Benefits from College Instruction (1970)Economic Efficiency and the D…The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications (2017)The Implementation of Managed…Italian risk-sharing agreements on drugs: are they worthwhile? (2014)Italian risk-sharing agreemen…Operationalizing Value-Based Pricing of Medicines (2012)Operationalizing Value-Based …Risk-Sharing Arrangements That Link Payment For Drugs To Health Outcomes Are Proving Hard To Implement (2011)Risk-Sharing Arrangements Tha…COST‐MINIMISATION ANALYSIS VERSUS COST‐EFFECTIVENESS ANALYSIS, REVISITED (2011)COST‐MINIMISATION ANALYSIS VE…The Pure Theory of Public Expenditure (1954)Research on Teaching College Economics: A Survey (1979)Negotiation arithmetic: adding and subtracting issues and parties (1983)Theory, Ideal Theory and the Theory of Ideals (2012)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents (1989)QALYs and the equity-efficiency trade-off (1991)Assessing the costs of healthcare technologies in clinical trials. (1999)Cost effectiveness analysis in health care: contraindications (2002)Opportunity costs and uncertainty in the economic evaluation of health care interventions (2002)Methods for the economic evaluation of health care programmes (1987)Interpretation of Changes in Health-related Quality of Life (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)Irreversibility, Uncertainty, and Cyclical Investment (1980)The Theory of Industrial Organization (1988)Irreversibility, Uncertainty, and Investment (1990)Coverage with Evidence Development: An examination of conceptual and policy issues (2007)A Practical Guide to Value of Information Analysis (2014)Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample (2015)Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force (2013)Managed Entry Agreements: Policy Analysis From the European Perspective (2020)PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE (1958)Measuring and Valuing Health Benefits for Economic Evaluation (2007)A mixed random utility — Random regret model linking the choice of decision rule to latent character traits (2013)How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide (2013)Measuring and Valuing Health Benefits for Economic Evaluation (2016)Implementation of Value-based Pricing for Medicines (2019)Information and Consumer Behavior (1970)Mental Accounting and Consumer Choice (1985)Consumer Perceptions of Price, Quality, and Value: A Means-End Model and Synthesis of Evidence (1988)Adoption Versus Adaptation, with Emphasis on Climate Change (2010)An exploratory inquiry into destination risk perceptions and risk reduction strategies of first time vs. repeat visitors to a highly volatile destination (2010)Effects of online retailer after delivery services on repurchase intention: An empirical analysis of customers’ past experience and future confidence with the retailer (2019)Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers (2010)Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers (2010)Pricing in the Market for Anticancer Drugs (2015)Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018)Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021)The Role of Securities in the Optimal Allocation of Risk-bearing (1964)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Review of statistical methods for analysing healthcare resources and costs (2010)Determinants of Risk: Exposure and Vulnerability (2012)
this work references cited by second hop

References

  • 2013Uncertainty and the Evaluation of Public Investment Decisions809 cited
  • 1970Economic Efficiency and the Distribution of Benefits from College Instruction448 cited
  • 2006Expected value of information and decision making in HTA185 cited
  • 1993Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.173 cited
  • 2001Demonstrations and money-back guarantees: market mechanisms to reduce uncertainty142 cited
  • 2002Valuation and management of money-back guarantee options87 cited

Cited by

  • 2017The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications122 cited
  • 2014Italian risk-sharing agreements on drugs: are they worthwhile?114 cited
  • 2011Risk-Sharing Arrangements That Link Payment For Drugs To Health Outcomes Are Proving Hard To Implement109 cited
  • 2012Operationalizing Value-Based Pricing of Medicines94 cited
  • 2011COST‐MINIMISATION ANALYSIS VERSUS COST‐EFFECTIVENESS ANALYSIS, REVISITED92 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work